Storm Bratchett Memorial Blood Drive March 3-4
Hoxworth Blood Center has announced the 13th Annual Storm Bratchett Memorial Blood Drive, scheduled for 11 a.m.-7 p.m., Thursday, March 3, and 11 a.m.-6 p.m., Friday, March 4, at Christ’s Community Church, located at 2433 25th St. in Portsmouth.
This event is the 13th memorial drive for Storm Bratchett, who was only 17 years old when accidentally shot in the chest with an arrow in 2008. He was rushed to the Southern Ohio Medical Center where doctors worked for hours to save his life, using more than 40 pints of blood. He did not survive.
“While Storm’s life was tragically cut short, his legacy lives on through this annual blood drive,” said Alecia Lipton, Hoxworth spokesperson. “We hope that the community will honor Storm’s selfless, giving spirit by making a lifesaving blood donation in his memory.”
Appointments for this drive are strongly encouraged, but walk-ins are welcome. Schedule an appointment by calling 513-451-0910 or visit www.hoxworth.org/groups/storm.
About Hoxworth:
Hoxworth Blood Center, University of Cincinnati, was founded in 1938, and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home. Replace with your text
Related Stories
EveryDay Health: Ways to manage symptoms linked to multiple...
March 26, 2024
The University of Cincinnati's Ed Faber spoke with EveryDay Health about ways to manage symptoms of multiple myeloma including numbness, pain or tingling in your arms and legs.
Spectrum News: Ohio Voices comes to Cincinnati
March 26, 2024
Ohio Voices, a video segment produced by Spectrum News, paid a visit to the University of Cincinnati to lift the voices of students, staff and faculty. Nine Bearcats were featured in the recent segment.
Collaborative University of Cincinnati Cancer Center team opens...
March 26, 2024
A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas, the most deadly form of brain tumors.